Dermatology Medical News about hepatitis C infection

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection
Clinical and Experimental Dermatology, 09/10/09

Wu JJ et al. – Patients with psoriasis and chronic hepatitis C virus (HCV) infection are a therapeutic challenge. Systemic psoriasis treatment with methotrexate and acitretin can be hepatotoxic, and interferon (IFN)–alpha for treatment of HCV can worsen psoriasis. Etanercept can be successfully used in patients with psoriasis and HCV.

<< Previous
Cutaneous annular sarcoidosis developing on a background of...

Next >>
Impact of Rac1 and Cdc42 Signaling during Early Herpes Simplex...

Acute hepatitis C and HIV coinfection
The Lancet Infectious Diseases, 11/19/09 Relevance Score: 82%

Silent Epidemic of Viral Hepatitis May Lead to Boom in Serious Liver Disease
JAMA, 11/12/09 Relevance Score: 82%

Predictors of Complication after Percutaneous Ultrasound-Guided Kidney Biopsy in HIV-Infected Individuals: Possible Role of Hepatitis C and HIV Co-infection
Clinical Journal of the American Society of Nephrology, 11/05/09 Relevance Score: 82%

The HLA-ER/HLA-ER Genotype Affects the Natural Course of Hepatitis C Virus (HCV) Infection and Is Associated with HLA-E–Restricted Recognition of an HCV-Derived Peptide by Interferon[gamma]–Secreting Human CD8+ T Cells
The Journal of Infectious Diseases, 10/14/09 Relevance Score: 81%

GPs key in hepatitis C campaign
Internet Source, 10/12/09 Relevance Score: 81%